Search
TFX · Company research

Teleflex Incorporated (TFX): Stock News & Events

Recent company-linked news records available in the database.

Main stock researchCompare stocks
RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

31records availableHealthcare

Stock News & Events data

Database-backed records only

31 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Teleflex (TFX) Completes BIOMAG LL Enrollment, Is The Stock Still A Bargain? - Simply Wall StreetTeleflex (TFX) Completes BIOMAG LL Enrollment, Is The Stock Still A Bargain? Simply Wall StreetView source ↗Simply Wall StreetOct 19, 2026neutral00.6
1 Value Stock with Exciting Potential and 2 Facing Challenges - Yahoo Finance1 Value Stock with Exciting Potential and 2 Facing Challenges Yahoo FinanceView source ↗Yahoo FinanceOct 19, 2026neutral00.6
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo! Finance CanadaTeleflex Incorporated (TFX) Stock Forecasts Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 17, 2026neutral00.6
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo FinanceTeleflex Incorporated (TFX) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Truist Securities Adjusts Teleflex Price Target to $142 From $150, Maintains Hold Rating - Yahoo FinanceTruist Securities Adjusts Teleflex Price Target to $142 From $150, Maintains Hold Rating Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Teleflex Incorporated (TFX) Stock Price, News, Quote & History - Yahoo! Finance CanadaTeleflex Incorporated (TFX) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 13, 2026neutral00.6
Teleflex Incorporated (TFX) Stock forecasts - Yahoo Finance UKTeleflex Incorporated (TFX) Stock forecasts Yahoo Finance UKView source ↗Yahoo Finance UKOct 13, 2026neutral00.6
Teleflex (TFX), What Is Drawing Fresh Attention To The Stock? - Simply Wall StreetTeleflex (TFX), What Is Drawing Fresh Attention To The Stock? Simply Wall StreetView source ↗Simply Wall StreetOct 12, 2026neutral00.6
102 patients joined a study of longer artery supports designed to be absorbed - Stock Titan102 patients joined a study of longer artery supports designed to be absorbed Stock TitanView source ↗Stock TitanOct 12, 2026neutral00.6
China Airway Management Market Forecast to 2033 - Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth OpportunitiesResearchAndMarkets.com released a comprehensive market report on China's airway management sector, covering historical data from 2018 and forecasts through 2033. The report segments the market into Airway Management Tubes and Intubation Accessories, providing revenue, volume, and pricing analysis. It includes 2025 company share data and profiles of key competitors to support strategic planning and investment decisions in this growing medical device market.View source ↗GlobeNewswire Inc.Oct 9, 2026neutral01
China Airway Management Market Forecast to 2033 - Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth OpportunitiesResearchAndMarkets.com released a comprehensive market report on China's airway management sector, covering historical data from 2018 and forecasts through 2033. The report segments the market into Airway Management Tubes and Intubation Accessories, providing revenue, volume, and pricing analysis. It includes 2025 company share data and profiles of key competitors to support strategic planning and investment decisions in this growing medical device market.View source ↗GlobeNewswire Inc.Oct 9, 2026neutral01
Bruker Gains 66.3% in a Year: What's Driving the Rally?Bruker Corporation (BRKR) shares gained 66.3% over the past year, driven by strong demand in biopharma, diagnostics, and mass spectrometry. However, the company faces a $134.9M goodwill impairment, currency headwinds, and restructuring costs. Full-year 2026 revenue guidance was lowered to $3.54-$3.57B due to currency pressures, though the company maintains a solid financial position with $184.9M in cash.View source ↗Zacks Investment ResearchOct 8, 2026bullish0.61
Bruker Gains 66.3% in a Year: What's Driving the Rally?Bruker Corporation (BRKR) shares gained 66.3% over the past year, driven by strong demand in biopharma, diagnostics, and mass spectrometry. However, the company faces a $134.9M goodwill impairment, currency headwinds, and restructuring costs. Full-year 2026 revenue guidance was lowered to $3.54-$3.57B due to currency pressures, though the company maintains a solid financial position with $184.9M in cash.View source ↗Zacks Investment ResearchOct 8, 2026bullish0.61
Bruker Gains 66.3% in a Year: What's Driving the Rally?Bruker Corporation (BRKR) shares gained 66.3% over the past year, driven by strong demand in biopharma, diagnostics, and mass spectrometry. However, the company faces a $134.9M goodwill impairment, currency headwinds, and restructuring costs. Full-year 2026 revenue guidance was lowered to $3.54-$3.57B due to currency pressures, though the company maintains a solid financial position with $184.9M in cash.View source ↗Zacks Investment ResearchOct 8, 2026bullish0.61
Reasons to Add Globus Medical Stock to Your Portfolio NowGlobus Medical (GMED) reported strong Q2 2026 performance with musculoskeletal revenues rising 7.5% and base business sales up 10.9%. The company continues to gain market share through product innovation, with over 60 development projects underway. However, foreign exchange volatility remains a concern. GMED maintains a debt-free balance sheet with $507.7 million in cash, supporting continued R&D and expansion investments.View source ↗Zacks Investment ResearchOct 7, 2026bullish11
Charles River Gains 75.8% in a Year: What's Driving the Rally?Charles River Laboratories (CRL) has outperformed the market with a 75.8% share price increase over the past year, driven by strong Research Models and Services (RMS) prospects and adoption of new approach methodologies. However, the company faces headwinds from uneven demand recovery across client segments, with small and midsized biotech revenues flat and currency fluctuations impacting reported growth. The company maintains a Zacks Rank #3 (Hold) rating.View source ↗Zacks Investment ResearchOct 7, 2026bullish0.751
Reasons to Add Globus Medical Stock to Your Portfolio NowGlobus Medical (GMED) reported strong Q2 2026 performance with musculoskeletal revenues rising 7.5% and base business sales up 10.9%. The company continues to gain market share through product innovation, with over 60 development projects underway. However, foreign exchange volatility remains a concern. GMED maintains a debt-free balance sheet with $507.7 million in cash, supporting continued R&D and expansion investments.View source ↗Zacks Investment ResearchOct 7, 2026bullish11
Charles River Gains 75.8% in a Year: What's Driving the Rally?Charles River Laboratories (CRL) has outperformed the market with a 75.8% share price increase over the past year, driven by strong Research Models and Services (RMS) prospects and adoption of new approach methodologies. However, the company faces headwinds from uneven demand recovery across client segments, with small and midsized biotech revenues flat and currency fluctuations impacting reported growth. The company maintains a Zacks Rank #3 (Hold) rating.View source ↗Zacks Investment ResearchOct 7, 2026bullish0.751
TFX or SONVY: Which Is the Better Value Stock Right Now?In a comparison of two Medical Instruments stocks, Teleflex (TFX) emerges as the better value opportunity compared to SONOVA HOLDING (SONVY). TFX has a superior Zacks Rank of #2 (Buy) versus SONVY's #3 (Hold), along with more attractive valuation metrics including a lower forward P/E ratio of 17.36 versus 21.87, a PEG ratio of 0.84 versus 2.42, and a P/B ratio of 1.91 versus 5.51. TFX earned a Value grade of B while SONVY received a D grade.View source ↗Zacks Investment ResearchOct 6, 2026neutral01
TFX or SONVY: Which Is the Better Value Stock Right Now?In a comparison of two Medical Instruments stocks, Teleflex (TFX) emerges as the better value opportunity compared to SONOVA HOLDING (SONVY). TFX has a superior Zacks Rank of #2 (Buy) versus SONVY's #3 (Hold), along with more attractive valuation metrics including a lower forward P/E ratio of 17.36 versus 21.87, a PEG ratio of 0.84 versus 2.42, and a P/B ratio of 1.91 versus 5.51. TFX earned a Value grade of B while SONVY received a D grade.View source ↗Zacks Investment ResearchOct 6, 2026neutral01
TFX or SONVY: Which Is the Better Value Stock Right Now? - Yahoo FinanceTFX or SONVY: Which Is the Better Value Stock Right Now? Yahoo FinanceView source ↗Yahoo FinanceOct 6, 2026neutral00.6
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?Teleflex (TFX) reported Q2 2026 Vascular revenue growth of 9% driven by central access and hemostatic product demand, with Asia revenues jumping 59.5%. However, tariffs and acquisition costs pressured margins, with adjusted operating margin declining 520 basis points. The company improved its balance sheet with pro forma net leverage at 1.9X after debt repayment.View source ↗Zacks Investment ResearchOct 6, 2026bullish0.751
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?Teleflex (TFX) reported Q2 2026 Vascular revenue growth of 9% driven by central access and hemostatic product demand, with Asia revenues jumping 59.5%. However, tariffs and acquisition costs pressured margins, with adjusted operating margin declining 520 basis points. The company improved its balance sheet with pro forma net leverage at 1.9X after debt repayment.View source ↗Zacks Investment ResearchOct 6, 2026bullish0.751
Teleflex Incorporated (NYSE:TFX) Stock Now Rated "Moderate Buy" by Wall Street Brokerages - MarketBeatTeleflex Incorporated (NYSE:TFX) Stock Now Rated "Moderate Buy" by Wall Street Brokerages MarketBeatView source ↗MarketBeatOct 6, 2026neutral00.6
Why Teleflex (TFX) Stock Is Up Today - Quiver QuantitativeWhy Teleflex (TFX) Stock Is Up Today Quiver QuantitativeView source ↗Quiver QuantitativeSep 28, 2026neutral00.6
Teleflex TFX Stock Steadies As Board And Stent News Build Momentum - StocksToTradeTeleflex TFX Stock Steadies As Board And Stent News Build Momentum StocksToTradeView source ↗StocksToTradeSep 28, 2026neutral00.6
Why Teleflex (TFX) Stock Is Trading Up Today - Yahoo FinanceWhy Teleflex (TFX) Stock Is Trading Up Today Yahoo FinanceView source ↗Yahoo FinanceSep 28, 2026neutral00.6
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock? - Yahoo FinanceTeleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock? Yahoo FinanceView source ↗Yahoo FinanceSep 28, 2026neutral00.6
3 Reasons to Avoid TFX and 1 Stock to Buy Instead - Yahoo Finance3 Reasons to Avoid TFX and 1 Stock to Buy Instead Yahoo FinanceView source ↗Yahoo FinanceSep 28, 2026neutral00.6
Teleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales - Yahoo FinanceTeleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales Yahoo FinanceView source ↗Yahoo FinanceAug 29, 2026neutral00.6
Why Is Teleflex (TFX) Stock Rocketing Higher Today - StockStoryWhy Is Teleflex (TFX) Stock Rocketing Higher Today StockStoryView source ↗StockStoryMay 7, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.